Among these mutations, TP53, NOTCH1, SF3B1, and BIRC3 have been established as prognostic factors for the course of CLL and proposed to be incorporated in CLL prognostic scales [18,19,20]. This evidence concerns the gene BIRC3 and B-cell chronic lymphocytic leukemia.